Regeneron
Regeneron Pharmaceuticals is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines, including EYLEA and EYLEA HD for ophthalmology, Dupixent in immunology (co-developed with Sanofi), Libtayo and Lynozyfic in oncology and hematology, and Praluent for cardiovascular disease. Regeneron does not publish a public developer API; its Regeneron Genetics Center collaborates on large-scale genomic research via the UK Biobank, DiscovEHR, and partner platforms rather than a self-hosted API.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Regeneron the way a machine reads it — 10 machine-readable artifacts, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Regeneron scores 10.2/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Regeneron
Each block below is one kind of artifact we hold for Regeneron. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Features 6
The notable capabilities this provider advertises, captured as structured features so they can be searched and compared instead of read one landing page at a time.
Notable capabilities this provider offers.
Ophthalmology
EYLEA and EYLEA HD anti-VEGF therapies for retinal diseases
Immunology
Dupixent for atopic dermatitis, asthma, and other IL-4/IL-13 indications
Oncology and Hematology
Libtayo, Lynozyfic, and pipeline programs in oncology
Rare Diseases
Evkeeza, Veopoz, and other rare-disease therapies
Infectious Disease
Inmazeb antibody cocktail for Ebola
Genetics Research
Regeneron Genetics Center sequencing collaborations including UK Biobank
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Use Cases 3
What developers actually build with this provider — captured so the catalogue answers 'what is this for', not just 'what does this expose'.
What developers build with this provider.
Clinical Trial Discovery
Patients and HCPs locate Regeneron-sponsored trials
Drug Information
HCPs access prescribing information for Regeneron medicines
Genomic Discovery
Researchers partner with the Regeneron Genetics Center on large-cohort sequencing
Resources
Every other property we hold for Regeneron — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Get Started 1
Portal, sign-up, and the first successful call
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Company 4
The organization behind the API
Other 1
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/regeneron · machine-readable index on apis.io